Ka C - Search Results

1

Deletion of the 5'ABL region in Philadelphia chromosome positive chronic myeloid leukemia: frequency, origin and prognosis.

Morel F, Ka C, Le Bris MJ, Herry A, Morice P, Bourquard P, Abgrall JF, Berthou C, De Braekeleer M. Morel F, et al. Among authors: ka c. Leuk Lymphoma. 2003 Aug;44(8):1333-8. doi: 10.1080/1042819031000097384. Leuk Lymphoma. 2003. PMID: 12952226

2

Deletion of the 5' abl region in Philadelphia chromosome-positive chronic myeloid leukemia.

Morel F, Ka C, Le Bris MJ, Herry A, Morice P, Bourquard P, Abgrall JF, Berthou C, De Braekeleer M. Morel F, et al. Among authors: ka c. Leukemia. 2003 Feb;17(2):473-4. doi: 10.1038/sj.leu.2402816. Leukemia. 2003. PMID: 12592354 No abstract available.

3

The p.Leu96Pro Missense Mutation in the BMP6 Gene Is Repeatedly Associated With Hyperferritinemia in Patients of French Origin.

Le Gac G, Gourlaouen I, Ka C, Férec C. Le Gac G, et al. Among authors: ka c. Gastroenterology. 2016 Oct;151(4):769-70. doi: 10.1053/j.gastro.2016.03.054. Epub 2016 Aug 30. Gastroenterology. 2016. PMID: 27590690 No abstract available.

4

The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype.

Le Gac G, Scotet V, Ka C, Gourlaouen I, Bryckaert L, Jacolot S, Mura C, Férec C. Le Gac G, et al. Among authors: ka c. Hum Mol Genet. 2004 Sep 1;13(17):1913-8. doi: 10.1093/hmg/ddh206. Epub 2004 Jul 14. Hum Mol Genet. 2004. PMID: 15254010

5

Impact of HFE genetic testing on clinical presentation of hereditary hemochromatosis: new epidemiological data.

Scotet V, Le Gac G, Mérour MC, Mercier AY, Chanu B, Ka C, Mura C, Nousbaum JB, Férec C. Scotet V, et al. Among authors: ka c. BMC Med Genet. 2005 Jun 1;6:24. doi: 10.1186/1471-2350-6-24. BMC Med Genet. 2005. PMID: 15929798 Free PMC article.

6

The Q283P amino-acid change in HFE leads to structural and functional consequences similar to those described for the mutated 282Y HFE protein.

Ka C, Le Gac G, Dupradeau FY, Rochette J, Férec C. Ka C, et al. Hum Genet. 2005 Sep;117(5):467-75. doi: 10.1007/s00439-005-1307-y. Epub 2005 Jun 18. Hum Genet. 2005. PMID: 15965644

7

Phenotypic and functional data confirm causality of the recently identified hemojuvelin p.r176c missense mutation.

Ka C, Le Gac G, Letocart E, Gourlaouen I, Martin B, Férec C. Ka C, et al. Haematologica. 2007 Sep;92(9):1262-3. doi: 10.3324/haematol.11247. Haematologica. 2007. PMID: 17768121 Free article.

8

A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin-associated iron overload diseases.

Létocart E, Le Gac G, Majore S, Ka C, Radio FC, Gourlaouen I, De Bernardo C, Férec C, Grammatico P. Létocart E, et al. Among authors: ka c. Br J Haematol. 2009 Nov;147(3):379-85. doi: 10.1111/j.1365-2141.2009.07834.x. Epub 2009 Aug 25. Br J Haematol. 2009. PMID: 19709084 Free article.

9

Le Gac G, Ka C, Gourlaouen I, Bryckaert L, Mercier AY, Chanu B, Scotet V, Férec C. Le Gac G, et al. Among authors: ka c. Adv Hematol. 2009;2009:251701. doi: 10.1155/2009/251701. Epub 2009 Nov 5. Adv Hematol. 2009. PMID: 19960042 Free PMC article.

10

Establishment of a medium-throughput approach for the genotyping of RHD variants and report of nine novel rare alleles.

Fichou Y, Le Maréchal C, Jamet D, Bryckaert L, Ka C, Audrézet MP, Le Gac G, Dupont I, Chen JM, Férec C. Fichou Y, et al. Among authors: ka c. Transfusion. 2013 Aug;53(8):1821-8. doi: 10.1111/trf.12009. Epub 2012 Dec 11. Transfusion. 2013. PMID: 23228153 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters